65 related articles for article (PubMed ID: 16000558)
21. Targeting Epstein-Barr virus oncoprotein LMP1-mediated glycolysis sensitizes nasopharyngeal carcinoma to radiation therapy.
Xiao L; Hu ZY; Dong X; Tan Z; Li W; Tang M; Chen L; Yang L; Tao Y; Jiang Y; Li J; Yi B; Li B; Fan S; You S; Deng X; Hu F; Feng L; Bode AM; Dong Z; Sun LQ; Cao Y
Oncogene; 2014 Sep; 33(37):4568-78. PubMed ID: 24662831
[TBL] [Abstract][Full Text] [Related]
22. Serum CXCL9 levels are associated with tumor progression and treatment outcome in patients with nasopharyngeal carcinoma.
Hsin LJ; Kao HK; Chen IH; Tsang NM; Hsu CL; Liu SC; Chang YS; Chang KP
PLoS One; 2013; 8(11):e80052. PubMed ID: 24278236
[TBL] [Abstract][Full Text] [Related]
23. The independent, unfavorable prognostic factors endothelin A receptor and chemokine receptor 4 have a close relationship in promoting the motility of nasopharyngeal carcinoma cells via the activation of AKT and MAPK pathways.
Luo DH; Chen QY; Liu H; Xu LH; Zhang HZ; Zhang L; Tang LQ; Mo HY; Huang PY; Guo X; Mai HQ
J Transl Med; 2013 Aug; 11():203. PubMed ID: 23987636
[TBL] [Abstract][Full Text] [Related]
24. Tyrosylprotein sulfotransferase-1 and tyrosine sulfation of chemokine receptor 4 are induced by Epstein-Barr virus encoded latent membrane protein 1 and associated with the metastatic potential of human nasopharyngeal carcinoma.
Xu J; Deng X; Tang M; Li L; Xiao L; Yang L; Zhong J; Bode AM; Dong Z; Tao Y; Cao Y
PLoS One; 2013; 8(3):e56114. PubMed ID: 23472069
[TBL] [Abstract][Full Text] [Related]
25. Upregulation of C-X-C chemokine receptor type 1 expression is associated with late-stage gastric adenocarcinoma.
Wang JP; Hu WM; Wang KS; Luo BH; Wu C; Chen ZH; Luo GQ; Liu YW; Liu QL; Yu J; Li JH; Wen JF
Exp Ther Med; 2012 Jul; 4(1):55-60. PubMed ID: 23060922
[TBL] [Abstract][Full Text] [Related]
26. CXCR4/SDF-1 axis is involved in lymph node metastasis of gastric carcinoma.
Zhao BC; Wang ZJ; Mao WZ; Ma HC; Han JG; Zhao B; Xu HM
World J Gastroenterol; 2011 May; 17(19):2389-96. PubMed ID: 21633638
[TBL] [Abstract][Full Text] [Related]
27. The Epstein-Barr virus-encoded G protein-coupled receptor BILF1 hetero-oligomerizes with human CXCR4, scavenges Gαi proteins, and constitutively impairs CXCR4 functioning.
Nijmeijer S; Leurs R; Smit MJ; Vischer HF
J Biol Chem; 2010 Sep; 285(38):29632-41. PubMed ID: 20622011
[TBL] [Abstract][Full Text] [Related]
28. Correlation effect of EGFR and CXCR4 and CCR7 chemokine receptors in predicting breast cancer metastasis and prognosis.
Liu Y; Ji R; Li J; Gu Q; Zhao X; Sun T; Wang J; Li J; Du Q; Sun B
J Exp Clin Cancer Res; 2010 Feb; 29(1):16. PubMed ID: 20181250
[TBL] [Abstract][Full Text] [Related]
29. Chemokine receptor CXCR4 expression in hepatocellular carcinoma patients increases the risk of bone metastases and poor survival.
Xiang ZL; Zeng ZC; Tang ZY; Fan J; Zhuang PY; Liang Y; Tan YS; He J
BMC Cancer; 2009 Jun; 9():176. PubMed ID: 19508713
[TBL] [Abstract][Full Text] [Related]
30. Fatal fast-evolution of nasopharyngeal squamous cell carcinoma in an HIV patient with EBV and HPV (-16 AND -33) in blood serum.
Sirera G; Videla S; Romeu J; Cañadas M; Fernández MT; Balo S; Cirauqui B; Darwich L; Rey-Joly C; Clotet B
Open AIDS J; 2008; 2():1-2. PubMed ID: 18923693
[TBL] [Abstract][Full Text] [Related]
31. CXCR4 in Cancer and Its Regulation by PPARgamma.
Richard CL; Blay J
PPAR Res; 2008; 2008():769413. PubMed ID: 18779872
[TBL] [Abstract][Full Text] [Related]
32. Chemokines as therapeutic targets in renal cell carcinoma.
Reckamp KL; Strieter RM; Figlin RA
Expert Rev Anticancer Ther; 2008 Jun; 8(6):887-93. PubMed ID: 18533798
[TBL] [Abstract][Full Text] [Related]
33. G-protein coupled chemoattractant receptors and cancer.
Huang J; Chen K; Gong W; Dunlop NM; Wang JM
Front Biosci; 2008 May; 13():3352-63. PubMed ID: 18508437
[TBL] [Abstract][Full Text] [Related]
34. Endothelial cells enhance tumor cell invasion through a crosstalk mediated by CXC chemokine signaling.
Warner KA; Miyazawa M; Cordeiro MM; Love WJ; Pinsky MS; Neiva KG; Spalding AC; Nör JE
Neoplasia; 2008 Feb; 10(2):131-9. PubMed ID: 18283335
[TBL] [Abstract][Full Text] [Related]
35. Chemokines in tumor angiogenesis and metastasis.
Singh S; Sadanandam A; Singh RK
Cancer Metastasis Rev; 2007 Dec; 26(3-4):453-67. PubMed ID: 17828470
[TBL] [Abstract][Full Text] [Related]
36. The anti-cancer compound Nordy inhibits CXCR4-mediated production of IL-8 and VEGF by malignant human glioma cells.
Ping YF; Yao XH; Chen JH; Liu H; Chen DL; Zhou XD; Wang JM; Bian XW
J Neurooncol; 2007 Aug; 84(1):21-9. PubMed ID: 17415525
[TBL] [Abstract][Full Text] [Related]
37. Clinical utilization of chemokines to combat cancer: the double-edged sword.
Dell'Agnola C; Biragyn A
Expert Rev Vaccines; 2007 Apr; 6(2):267-83. PubMed ID: 17408375
[TBL] [Abstract][Full Text] [Related]
38. Chemokine expression in hepatocellular carcinoma versus colorectal liver metastases.
Rubie C; Frick VO; Wagner M; Weber C; Kruse B; Kempf K; König J; Rau B; Schilling M
World J Gastroenterol; 2006 Nov; 12(41):6627-33. PubMed ID: 17075975
[TBL] [Abstract][Full Text] [Related]
39. The expression of functional chemokine receptor CXCR4 is associated with the metastatic potential of human nasopharyngeal carcinoma.
Hu J; Deng X; Bian X; Li G; Tong Y; Li Y; Wang Q; Xin R; He X; Zhou G; Xie P; Li Y; Wang JM; Cao Y
Clin Cancer Res; 2005 Jul; 11(13):4658-65. PubMed ID: 16000558
[TBL] [Abstract][Full Text] [Related]
40. Chemokine receptor expression profiles in nasopharyngeal carcinoma and their association with metastasis and radiotherapy.
Ou DL; Chen CL; Lin SB; Hsu CH; Lin LI
J Pathol; 2006 Nov; 210(3):363-73. PubMed ID: 16955398
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
